Yahoo
ASX - Delayed Quote AUD

ImExHS Limited (IME.AX)

0.3450 +0.0150 (+4.55%)
At close: October 30 at 10:24:27 AM GMT+11
Chart Range Bar
Loading chart for IME.AX
  • Previous Close 0.3300
  • Open 0.3300
  • Bid 0.3400 x --
  • Ask 0.3450 x --
  • Day's Range 0.3300 - 0.3450
  • 52 Week Range 0.2500 - 0.4700
  • Volume 9,272
  • Avg. Volume 9,169
  • Market Cap (intraday) 18.767M
  • Beta (5Y Monthly) 0.84
  • PE Ratio (TTM) --
  • EPS (TTM) 0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 0.37

ImExHS Limited offers cloud-based medical imaging solutions in Australia and internationally. The company operates in two segments: Software and Radiology. It offers medical imaging software that is focused on the development and sale of modular imaging systems, which include information systems for radiology, cardiology, and pathology, as well as a picture archiving and communications system. The company's solutions include AQUILA, a radiology software solution; ALULA, a pathology software solution; and ANTEROS, a cardiology software solution. It also provides radiological diagnostic services to hospitals and medical facilities; medical images and radiologists' interpretation; reports to develop artificial intelligence (AI) tools; and outsourced radiology services, as well as teleradiology services. ImExHS Limited was incorporated in 2001 and is based in Sydney, Australia.

www.imexhs.com

290

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .

YTD Return

IME.AX
13.75%
S&P/ASX 200 [XJO] (^AXJO)
2.22%

1-Year Return

IME.AX
27.78%
S&P/ASX 200 [XJO] (^AXJO)
0.29%

3-Year Return

IME.AX
50.71%
S&P/ASX 200 [XJO] (^AXJO)
31.37%

5-Year Return

IME.AX
72.90%
S&P/ASX 200 [XJO] (^AXJO)
21.63%

Analyst Insights

View More

Analyst Price Targets

0.37
0.37 Average
0.3450 Current
0.37 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 10/30/2026
  • Market Cap

    18.77M

  • Enterprise Value

    17.24M

  • Trailing P/E

    373.38

  • Forward P/E

    --

  • PEG Ratio (current)

    --

  • Price/Sales (ttm)

    0.57

  • Price/Book (mrq)

    1.09

  • Enterprise Value/Revenue

    0.55

  • Enterprise Value/EBITDA

    7.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.60%

  • Return on Assets (ttm)

    0.51%

  • Return on Equity (ttm)

    1.19%

  • Revenue (ttm)

    31.27M

  • Net Income Avi to Common (ttm)

    188.61k

  • Diluted EPS (ttm)

    0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.99M

  • Total Debt/Equity (mrq)

    2.65%

  • Levered Free Cash Flow (ttm)

    -672.04k

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: